SCHEMBL2549908

SCHEMBL2549908

O=P(Oc1ccc(O)c2ccccc12)(Oc1ccc(O)c2ccccc12)Oc1ccc(O)c2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 4/20 0.52
ESR1 P03372 6/20 0.42
ESR2 Q92731 6/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
GAA P10253 2/20 0.42
JAK2 O60674 1/20 0.42
USP2 O75604 1/20 0.42
MAPT P10636 1/20 0.42
ALOX15 P16050 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HSD17B10 Q99714 1/20 0.42
EP300 Q09472 3/20 0.42
KAT2B Q92831 3/20 0.42
KAT8 Q9H7Z6 3/20 0.42
HDAC3 O15379 1/20 0.42
NCOR2 Q9Y618 1/20 0.42
LDHA P00338 1/20 0.41
CTSB P07858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2541603 0.86 INPPL1 (0.50) IDO1ESR1ESR2MEN1KMT2A
SCHEMBL27595065 0.85 IDO1 (0.45) IDO1ESR1ESR2MEN1KMT2A
Benzene SCHEMBL28642827 0.83 IDO1 (0.46) IDO1ESR1ESR2MEN1KMT2A
SCHEMBL9274496 0.78 TSHR (0.44) IDO1ESR1ESR2KMT2AUSP2
SCHEMBL234536 0.78 SRC (0.48) MEN1KMT2A
Toluene SCHEMBL28657685 0.77 ESR1 (0.41) IDO1ESR1ESR2MEN1KMT2A
SCHEMBL1581774 0.76 IDO1 (0.65) IDO1ESR1ESR2MEN1KMT2A
SCHEMBL2547019 0.76 IDO1 (0.57) IDO1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL8384662 0.74 INPPL1 (0.57) ESR1ESR2MEN1KMT2AGAA
SCHEMBL1685758 0.74 GAA (0.53) KMT2AGAAJAK2USP2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10155973-B2 Methods for detecting organisms and enzymatic reactions using raman spectroscopy and aromatic compounds comprising phosphate SWORD DIAGNOSTICS, INC. (US) 2018-12-18 US disclosed
US-20150218615-A1 METHODS FOR DETECTING ORGANISMS AND ENZYMATIC REACTIONS USING RAMAN SPECTROSCOPY AND AROMATIC COMPOUNDS COMPRISING PHOSPHATE SWORD DIAGNOSTICS, INC. (US) 2015-08-06 US disclosed
EP-2553117-A1 METHODS FOR DETECTING RAMAN SCATTERING USING AROMATIC COMPOUNDS COMPRISING PHOSPHATE AND AT LEAST ONE NON-LASER LIGHT SOURCE Sword Diagnostics, Inc. (US) 2013-02-06 EP disclosed
WO-2011123386-A1 METHODS FOR DETECTING RAMAN SCATTERING USING AROMATIC COMPOUNDS COMPRISING PHOSPHATE AND AT LEAST ONE NON-LASER LIGHT SOURCE KUNDU SAMAR KUMAR (US) 2011-10-06 WO disclosed
US-20100041016-A1 METHODS FOR DETECTING ORGANISMS AND ENZYMATIC REACTIONS USING RAMAN SPECTROSCOPY AND AROMATIC COMPOUNDS COMPRISING PHOSPHATE SWORD DIAGNOSTICS, INC. 2010-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041016-A1 METHODS FOR DETECTING ORGANISMS AND ENZYMATIC REACTIONS USING RAMAN SPECTROSCOPY AND AROMATIC COMPOUNDS COMPRISING PHOSPHATE PNP, ARSA, PGLS IDO1 1969/4885ESR1 3147/4885ESR2 3804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.